The author discusses the clinical impact of genomic testing on the diagnosis of prostate cancer. Several products used in genomic testing are examined including Deicpher from GenomeDx, Oncotype from Genomic Health Inc. and Prolaris from Myriad Genetics Inc. The types of genes and tissues to be tested are described.